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With a complex chemical composition rich in phenolic compounds, propolis (resinous substance collected by Apis mellifera from
various tree buds) exhibits a broad spectrum of biological activities. Recently, in vitro and in vivo data suggest that propolis has
anticancer properties, but is the cytoxicity of propolis specific for tumor cells? To answer this question, the cytotoxicity of phenolic
extracts from Portuguese propolis of different origins was evaluated using human tumor cell lines (MCF7—breast adenocarcinoma,
NCI-H460—non-small cell lung carcinoma, HCT15—colon carcinoma, HeLa—cervical carcinoma, and HepG2—hepatocellular
carcinoma), and non-tumor primary cells (PLP2). The studied propolis presented high cytotoxic potential for human tumor cell
lines, mostly for HCT15. Nevertheless, excluding HCT15 cell line, the extracts at the GI
50
obtained for tumor cell lines showed, in
general, cytotoxicity for normal cells (PLP2). Propolis phenolic extracts comprise phytochemicals that should be further studied
for their bioactive properties against human colon carcinoma. In the other cases, the proximity of the in vitro cytotoxic doses for
tumor and normal cell lines should be confirmed by in vivo tests and may highlight the need for selection of specific compounds
within the propolis extract.
1. Introduction
Epidemiological data support the concept that natural prod-
ucts, in special, phenols and polyphenols in diet are safe and
nontoxic and have long-lasting beneficial effects on human
health. Among the many biological properties presented by
them, the ones involved with cancer therapy are remarkable
[1].
Many plants rich in polyphenols have been shown to
display interesting anticancer effects on cell lines and murine
models, yielding higher effects when compared to pure
natural or synthetic compounds [1]. Products originating in
the beehive, such as honey, pollen, royal jelly, and propolis,
are attractive both as ingredients for healthy foods and as
medicinal products in apitherapy [2, 3].
Propolis is a chemically complex product obtained by
bees from the resinous exudates of leaf buds, shoots, and
petioles of leaves of different plants present around the
hive, which is mixed with wax and salivary secretions. In
the hive it has a multifunctional role as a material for
construction, maintenance, and defense [4]. Named as bee
glue, its chemical composition is highly variable and strongly
dependent on the plant sources available around the hive.
Furthermore, the propolis composition is dependent on the
seasonality, altitude, collector type, food availability, and
activity developed during propolis exploitation [5]. More
than 300 chemical compounds were identified in propolis
from different regions [6, 7]. The main chemical classes and
most bioactive compounds found in propolis are the phenolic
compounds, including phenolic acids, flavonoids, and their
derivatives [6, 8].
Propolis has a wide spectrum of biological and pharma-
cological properties, which have been intensively researched
in cell and animal experiments and thus it can be considered
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as a drug from the beehive [3]. Recently, studies concerning
propolis and cancer have been attracting researchers [9–11].
Propolis and its components, namely, caffeic acid, caffeic acid
phenethyl ester (CAPE), 3,5-diprenyl-4-hydroxycinnamic
acid (artepillin C), and others, are frequently mentioned in
the literature as antitumor and immunomodulatory agents
[9, 10, 12]. Through in vitro and in vivo assays it was possible
to define different mechanisms of actions for the bee glue and
its components, such as suppressing cancer cells prolifera-
tion via its anti-inflammatory effects, decreasing the cancer
stem cell populations, blocking specific oncogene signaling
pathways, exerting antiangiogenic effects, and modulating
the tumor microenvironment [9–11].
Propolis phenolic profile from different Portuguese
regions was recently characterized and quantified through
high-pressure liquid chromatography (HPLC) and liquid
chromatography with diode-array detection coupled
to electrospray ionization tandem mass spectrometry
(LC/DAD/ESI −MSn ), providing identification of seventy-
six phenolic compounds [13, 14]. Within the biological
properties studied in Portuguese propolis, few studies deal
with anticancer effects. Two samples from the northeast
and center of Portugal strongly suppress the proliferation
of primary renal cancer cells in a concentration-dependent
manner [15]. Also, the in vitro antitumor activity of a propolis
sample from Azores archipelago was evaluated on colon
carcinoma cell line HCT15 presenting cytotoxicity in a dose-
and time-dependent way [16].
Due to the complex nature of propolis which strongly
depends on the local flora at the site of collection, for an
effective evaluation of the anticancer properties of Portuguese
propolis more regions have to be evaluated and the antitumor
assays should be extended for other types of cell lines.
Moreover, it is important to compare its cytotoxicity against
tumor and normal cells. In this context, this work aims to
study the growth inhibitory activity of phenolic extracts from
Portuguese propolis of different regions on human tumor cell
lines (MCF-7—breast adenocarcinoma, NCI-H460—non-
small cell lung carcinoma,HCT15—colon carcinoma,HeLa—
cervical carcinoma, and HepG2—hepatocellular carcinoma)
and nontumor primary cells (PLP2).
2. Material and Methods
2.1. Samples
2.1.1. Samples Origin. The study was performed on propolis
samples collected from five different geographical regions in
Portugal: north (N1, Braganc¸a; N8, Mirandela), central coast
(CC3,Coruche), south (S2,Aljezur), AzoresArchipelago (A2,
S. Miguel Island), and Madeira Island (M1, Funchal). All
the samples were obtained between 2007 and 2009 after the
honey harvesting season (July/September), by conventional
scraping or through plastic screens. These propolis samples
were then stored at −20∘C until analysis.
2.1.2. Phenolic Extracts Preparation. Theextractionwasmade
according to the work previously described [8]. Prior to the
extraction, 1 g of powdered propolis sample was homoge-
nized andmixedwith 10mL of 80%of ethanol/water and kept
at 70∘C for 1 h. The resulting mixtures were filtered and the
residues were reextracted in the same conditions. After the
second extraction, the filtrates were combined, concentrated,
and freeze-dried. Complete chemical characterization of the
phenolic extracts is available in Falca˜o et al. [13, 14] For
cytotoxicity evaluation, the extracts were dissolved in DMSO
at a final concentration of 8mg/mL. The final solutions were
further diluted to different concentrations. The results were
expressed in GI
50
(extract concentration that inhibited 50%
of the net cell growth) values. Ellipticine was used as positive
control.
2.2. Standards and Reagents. Fetal bovine serum (FBS), L-
glutamine, Hank’s balanced salt solution (HBSS), trypsin-
EDTA (ethylenediaminetetraacetic acid), pen-icillin/strep-
tomycin solution (100U/mL and 100mg/mL, resp.), RPMI-
1640, and DMEM media were from Hyclone (Logan, USA).
Acetic acid, ellipticine, sulforhodamine B (SRB), trypan
blue, trichloroacetic acid (TCA), and Tris were from Sigma
Chemical Co. (Saint Louis, USA). Water was treated in a
Milli-Q water purification system (TGI Pure Water Systems,
USA).
2.3. Evaluation of Cytotoxicity in Human Tumour Cell Lines
. Five human tumor cell lines were used: MCF-7 (breast
adenocarcinoma) from DSMZ (Leibniz-Institut DSMZ—
Deutsche Sammlung von Mikroorganismen und Zellkul-
turen GmbH), NCI-H460 (non-small cell lung carcinoma),
HCT15 (colon carcinoma), HeLa (cervical carcinoma), and
HepG2 (hepatocellular carcinoma) fromEuropean collection
of cell cultures (ECACC). Cells were routinely maintained as
adherent cell cultures in RPMI-1640 medium containing 10%
heat-inactivated FBS (MCF-7, NCI-H460, and HCT15) and
2mM glutamine or in DMEM supplemented with 10% FBS,
2mM glutamine, 100U/mL penicillin, and 100mg/mL strep-
tomycin (HeLa and HepG2 cells), at 37∘C, in a humidified
air incubator containing 5% CO
2
. Each cell line was plated
at an appropriate density (7.5 × 103 cells/well for MCF-7,
NCI-H460 and HCT15 or 1.0 × 104 cells/well for HeLa and
HepG2) in 96-well plates for 24 h. Cells were then treated
for 48 h with various extract concentrations. Following this
incubation period, the adherent cells were fixed by adding
cold 10% trichloroacetic acid (TCA, 100 𝜇L) and incubated
for 60min at 4∘C. Plates were then washed with deionized
water and dried; sulforhodamine B solution (0.1% in 1% acetic
acid, 100 𝜇L) was then added to each plate well and incubated
for 30min at room temperature. Unbound SRB was removed
by washing with 1% acetic acid. Plates were air-dried, the
bound SRB was solubilised with 10mMTris (200 𝜇L) and the
absorbance was measured at 540 nm in ELX800 Microplate
Reader (Bio-Tek Instruments, Inc; Winooski, USA) [17].
2.4. Evaluation of Cytotoxicity in a Porcine Liver Primary Cell
Culture. A cell culture was prepared from a freshly harvested
porcine liver obtained from a local slaughter house, and it
was designed as PLP2. Briefly, the liver tissues were rinsed in
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Hank’s balanced salt solution containing 100U/mL penicillin
and 100 𝜇g/mL streptomycin and divided into 1 × 1mm3
explants. Some of these explants were placed in 25 cm2 tissue
flasks inDMEMmedium supplementedwith 10% fetal bovine
serum, 2mM nonessential amino acids, 100U/mL penicillin,
and 100mg/mL streptomycin and incubated at 37∘C with
a humidified atmosphere containing 5% CO
2
. The medium
was changed every two days. Cultivation of the cells was
continued with direct monitoring every two to three days
using a phase contrast microscope. Before confluence was
reached, cells were subcultured and plated in 96-well plates
at a density of 1.0 × 104 cells/well and cultivated in DMEM
medium with 10% FBS, 100U/mL penicillin, and 100 𝜇g/mL
streptomycin [17].
2.5. Statistical Analysis. For all the experiments three samples
(𝑛 = 3) were analysed and all the assays were carried
out in triplicate. The results are expressed as mean values
and standard deviation (SD). The differences between the
different samples were analysed using one-way analysis of
variance (ANOVA) followed by Tukey’s honestly significant
difference post hoc test with 𝛼 = 0.05, coupled with Welch’s
statistic. This treatment was carried out using SPSS v. 18.0
program. The regression analysis between phenolic acids,
phenolic esters, total phenolics, flavonols, flavones, dihy-
droflavonols, flavanones, flavonoid esters, total flavonoids
(mg/g of extract), and cytotoxicity GI
50
values (𝜇g/mL) was
performed using the same statistical package.
3. Results
The cytotoxicity of the propolis phenolic extracts was evalu-
ated in five human tumor cell lines (breast-MCF7, lung-NCI-
H460, colon- HCT15, cervical- HeLa and hepatocellular-
HepG2, carcinomas) and in a porcine liver primary cell
culture (PLP2), established by us. All the studied extracts
inhibited the growth of the mentioned tumor cell lines.
N1 gave the highest cytotoxicity, followed by A2 (Table 1),
presenting the lowest GI
50
values against the tested tumor
cell lines. The HCT15 cell line was the most sensible to the
studied extracts, except to S2 extract, as the A2 extract was
the most active (GI
50
= 9 𝜇g/mL; an excellent GI
50
value
in comparison with several natural extracts, for example,
Guimara˜es et al. [17] This activity could be related to the
chemical composition of this sample (Figure 1). From the
analysis of Figure 1, it can be observed that samples N1 and
A2 havemajor concentrations of total phenolics and phenolic
acids, especially the sample N1.
Despite the lower concentration in total phenolics pre-
sented in the sample N8, the GI
50
values for MCF7 cell line
were not very different from the extracts N1 or A2, which can
be due to the similar high content in total flavonoids and the
specificity of this cell line to flavonoids.This sample presented
the major concentration of flavones and flavanones, two
important groups of compounds regarding biological activity.
The M1 sample from Madeira island showed the highest
GI
50
values for all the tested tumor cell lines. This fact could
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Figure 1: Phenolic classes presented in propolis of different Por-
tuguese origins. [14].
be explained by its poor chemical composition (Figure 1) that
only includes flavones and in low concentration.
The correlations established between the chemical com-
position and the cytotoxicity results are presented in Table 2.
The cytotoxicity observed for all the tested tumor cell lines,
except MCF7, was positively correlated with phenolic acids
(𝑅2 values higher than 0.5) and, consequently, with total
phenolic (𝑅2 higher than 0.5) contents but not with phenolic
esters (𝑅2 lower than 0.5). NCI-H460 cell line presented the
highest correlation for this class of compounds (𝑅2 = 0.9454).
Total flavonoids were positively correlated (𝑅2 values
higher than 0.5) with the cytotoxicity observed against
MCF7, NCI-H460, HCT15, and HeLa cell lines. However,
the cytotoxicity was not correlated (𝑅2 values lower than
0.5) with flavonols, dihydroflavonols, and flavonoid esters.
The cytotoxicity observed in HCT15 cell line was the one
that correlates better with the composition in phenolic
compounds.
The evaluation of the cytotoxicity using PLP2 is very
important since mammalian hepatocytes still represent an
obligatory step in the evaluation of toxic compounds that
lead to the production of various metabolites, which are the
ultimate cause of toxicity. We used porcine liver as an in
vitro cytotoxicity model because it is known, in terms of
cellular and physiological functioning, to be very similar to
human. Despite the high cytotoxicity displayed by most of
the propolis samples against tumor cell lines, the samples
also showed toxicity for nontumour (normal) liver primary
culture (PLP2), with GI
50
values close to those obtained for
tumor cell lines. The cytotoxicity for PLP2 primary culture
was only positively correlated with phenolic acids (𝑅2 =
0.7442) and consequently with total phenolics (𝑅2 = 0.6207).
The colon carcinoma cells, HCT15, seem to be the most
promising to be controlled by the studied propolis extracts
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Table 1: Cytotoxicity of phenolic extracts from Portuguese propolis of different origins (mean ± SD).
MCF-7
(breast carcinoma)
NCI-H460
(non-small
lung cancer)
HCT15
(colon carcinoma)
HeLa
(cervical carcinoma)
HepG2
(hepatocellular
carcinoma)
PLP2
(non-tumour liver
primary culture)
A2 39 ± 0 29 ± 2c 9 ± 1d 38 ± 4d 34 ± 4bc 35 ± 3d
CC3 37 ± 2d 30 ± 0c 12 ± 1d 40 ± 3d 34 ± 2bc 36 ± 1d
M1 182 ± 2a 166 ± 6a 120 ± 3a 182 ± 11a 153 ± 6a 180 ± 3a
N1 36 ± 1d 23 ± 1d 10 ± 1d 38 ± 3d 30 ± 3c 29 ± 3d
N8 41 ± 1c 34 ± 2bc 38 ± 5c 54 ± 4c 40 ± 3b 54 ± 7b
S2 47 ± 2b 37 ± 1b 50 ± 11b 84 ± 6b 36 ± 2bc 45 ± 1c
Ellipticine 0.91 ± 0.04 1.42 ± 0.00 1.91 ± 0.06 1.1 ± 0.2 3.2 ± 0.7 2.06 ± 0.03
GI50 values (𝜇g/mL) corresponding to the sample concentration achieving 50% of growth inhibition in human tumor cell lines or in liver primary cultured
PLP2.
In each column different letters mean significant differences (𝑃 < 0.05).
since, with exception of sample S2, all the cytotoxicity levels
for the tumor cells are significantly above the ones found for
nontumor PLP2 cells. The same behaviour was observed for
the NCI-H460 cell line; however, in this case the cytotoxicity
levels for tumor and nontumor cells are close which reduces
the selectivity. The sample from Madeira showed the lowest
cytotoxicity for all the tested tumor cell lines, which indicates
that the chemical composition of the samples has a significant
influence on their bioactivity, since this sample presented a
quite specific phenolic profile, only with flavones.
4. Discussion
The highest cytotoxicity revealed by samples N1 and A2
against all the tested tumor cell lines is certainly related to
their higher concentrations in total phenolics and phenolic
acids. Phenolic acids and analogues are, in fact, known to
display a wide variety of biological functions, in addition
to their primary antioxidant activity, which are mainly
related to modulation of carcinogenesis [18, 19]. Indeed,
many phenolic compounds have been investigated for their
potential use as cancer chemopreventive agents [1, 20]. There
are many reports on the bioactive constituents of propolis
like cinnamic acid esters, such as caffeic acid phenethyl
(CAPE), which is a component of propolis from honeybee
hives, and benzyl esters that display selective antiproliferative,
anticarcinogenic, and immunomodulatory properties [21,
22]. The molecular basis of this action may be connected to
the inhibition of the nuclear transcription factor NK-kappa B
[23]. Other authors refer that drupanin, baccharin, cinnamic
acid derivatives inhibit the growth of HeLa-60 cell lines by
inducing apoptosis [24].
The similar toxicity for MCF7 cell line observed between
N8,N1, andA2 can be explained by the similar high content in
total flavonoids, presenting N8 as the highest concentration
of flavones and flavanones. The most common compounds
within the flavones were apigenin, chrysin, and luteolin.They
are responsible for main benefits to human health including
anticarcinogenic effects [25]. In the flavanones group, hes-
peridin and naringin, the most important compounds, have
also been reported as possessing anticancer properties [25].
The present data highlights the high cytotoxicity of Por-
tuguese propolis against tumor cell lines, being in agreement
with Bu´falo et al. [26], who reported a marked activity of
Brazilian green propolis against other tumor cells (human
laryngeal epidermoid carcinoma (HEp-2)); the main mech-
anism seems to involve apoptosis [27]. Ethanol extract of
Brazilian red propolis was also reported as promoting a
significant reduction in MCF7 cell viability thought the
induction of mitochondrial dysfunction, caspase-3 activity,
and DNA fragmentation [28]. Moroccan propolis extracts
(ethanolic and ethyl acetate) were described as exerting
antiproliferative effect against BSR (hamster renal adeno-
carcinoma), Hep-2 (Human laryngeal carcinoma), and P815
(murine mastocytoma) in dose-dependent manner [29].
Similar results were obtained by Sulaiman et al. [30] with
Iraqi propolis, who described the inhibitory effects against
the proliferation of HL-60 and colony potential of HCT116
cells.
Despite the high cytotoxicity displayed by most of the
propolis samples against tumor cell lines studied herein,
the samples also showed toxicity for nontumour (normal)
liver primary culture (PLP2). da Silva Frozza et al. [31]
have also investigated the cytotoxicity of extracts of red
Brazilian propolis for two tumor cell lines (Hep-2 and HeLa)
and human normal epithelial embryonic kidney (Hek-293),
reporting also higher IC
50
value for Hek-293 when compared
to tumor cell lines.
5. Conclusions
Propolis phenolic extracts comprise phytochemicals that
should be further studied for their bioactive properties
against human colon carcinoma. In the other cases, the prox-
imity of the in vitro cytotoxic doses for tumor and normal cell
lines should be taken into consideration and confirmed by in
vivo tests. Additional research is needed to determine which
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compounds are involved in cytotoxicity against normal cells
in order to develop new propolis formulations without those
compounds to be selectively used against tumor cells.
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